Business Context and Reporting Period
Company: Evolv Technologies Holdings, Inc. (EVLV)
Filing Type: Form 10-Q (Unaudited)
Period Ended: September 30, 2025 (Q3 2025)
Business Overview: Evolv is a security technology company providing AI-powered screening solutions (Evolv Express and Evolv eXpedite) primarily through a Security-as-a-Service (SaaS) subscription model. The company serves venues including schools, hospitals, and public spaces.
Key Financial Metrics
| Metric (in thousands) | Q3 2025 | Q3 2024 | 9M 2025 | 9M 2024 |
|---|---|---|---|---|
| Total Revenue | $42,850 | $27,360 | $107,401 | $74,765 |
| Gross Profit | $21,306 | $15,809 | $56,674 | $42,721 |
| Gross Margin | 49.7% | 57.8% | 52.8% | 57.1% |
| Net Loss | $(1,796) | $(30,443) | $(44,020) | $(38,297) |
| Operating Cash Flow (9M) | $3,098 | $(34,057) | $3,098 | $(34,057) |
| Cash & Marketable Securities | $56,227 | $51,942 | $56,227 | $51,942 |
| Long-Term Debt | $28,528 | $0 | $28,528 | $0 |
Note: Q3 2025 Net Loss significantly improved due to non-cash fair value adjustments on liabilities.
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 57% year-over-year in Q3 2025, driven by a 588% surge in product revenue (shift to purchase subscription model) and 27% growth in subscription revenue.
- Profitability Improvement: Net loss narrowed from $30.4M in Q3 2024 to $1.8M in Q3 2025. This improvement is largely attributable to a $7.5M gain from the change in fair value of the contingent earn-out liability and a $2.2M gain on contingently issuable stock, offsetting a $2.6M loss on public warrants.
- Debt Financing: In July 2025, the company entered a $75M credit facility with MidCap Financial Trust. As of September 30, 2025, $30M of the initial term loan was drawn, resulting in $28.5M of outstanding debt (net of issuance costs).
- Operating Expenses: Sales and marketing expenses decreased 22% in Q3 2025 due to a reduction in force implemented in January 2025. General and administrative expenses decreased 10%.
- Inventory Management: Inventory decreased by $8.2M (48%) from year-end 2024 to Q3 2025, reflecting improved inventory management.
Guidance, Outlook, Risks, and Contingencies
- Debt Covenants: The company is currently in compliance with all covenants under the MidCap Credit Agreement. Key covenants include a minimum Annual Recurring Revenue (ARR) of $106M by Dec 31, 2025 (current ARR is $117.2M) and a minimum liquidity of 50% of outstanding borrowings.
- Legal Proceedings:
- Class Action: A settlement in principle of $15.0M has been reached regarding a securities class action lawsuit. The company estimates $14.0M will be covered by D&O insurance. A $15.0M accrual and $14.0M insurance recovery asset have been recorded.
- Regulatory: The company is cooperating with an SEC investigation regarding marketing practices and revenue recognition. The DOJ investigation was closed in August 2025. An FTC settlement requires compliance with marketing claims and record-keeping but involves no monetary relief.
- Internal Controls: Management concluded that disclosure controls and procedures were not effective as of September 30, 2025, due to material weaknesses in the control environment, revenue recognition, and IT general controls. These weaknesses led to restatements of prior financial statements.
- Supply Chain: The company entered a new contract manufacturing agreement with Plexus Corp. in November 2025 to diversify supply chain and reduce costs, though onboarding risks exist.
Investor Verification Checklist
- Restatement Impact: Verify the full scope of financial restatements for 2022, 2023, and 2024 and the specific accounting errors related to revenue recognition.
- Internal Control Remediation: Monitor the progress of the remediation plan for material weaknesses in internal controls over financial reporting.
- Debt Covenant Compliance: Track ARR and liquidity metrics to ensure continued compliance with the MidCap Credit Agreement covenants.
- Legal Settlement Finalization: Confirm the finalization of the $15M class action settlement and the actual receipt of the $14M insurance recovery.
- Revenue Mix Shift: Assess the long-term margin impact of the strategic shift from the "distributor licensing" model to the "purchase subscription" model.